SEC
SlamSEC
Search
Browse
Earnings
Kymera Therapeutics, Inc. — SlamSEC
Kymera Therapeutics, Inc.
Nasdaq:
KYMR
Biological Products, (No Diagnostic Substances)
·
WATERTOWN, MA
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
All Filings
(532 total)
Annual Reports
Quarterly Reports
Current Reports
Proxies
Registrations
Insider Activity
Ownership
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
Type
Date
Accession
Period
Size
4
Mar 4, 2026
0001193125-26-091986
4
Mar 2, 2026
6.9 KB
4
Mar 4, 2026
0001193125-26-091985
4
Mar 2, 2026
20.6 KB
4
Mar 4, 2026
0001193125-26-091984
4
Mar 2, 2026
7.0 KB
4
Mar 4, 2026
0001193125-26-091983
4
Mar 2, 2026
20.5 KB
4
Mar 4, 2026
0001193125-26-091982
4
Mar 2, 2026
20.4 KB
4
Mar 4, 2026
0001193125-26-091980
4
Mar 2, 2026
5.2 KB
4
Mar 4, 2026
0001451612-26-000002
Mar 2, 2026
7.8 KB
144
Mar 2, 2026
0001628280-26-013331
—
4.5 KB
144
Mar 2, 2026
0001628280-26-013330
—
4.5 KB
144
Mar 2, 2026
0001193125-26-085708
—
5.8 KB
144
Mar 2, 2026
0001193125-26-085705
—
5.1 KB
144
Mar 2, 2026
0001193125-26-085696
—
5.1 KB
8-K
Feb 26, 2026
0001193125-26-073561
8-K
Feb 26, 2026
395.9 KB
424B3
Feb 26, 2026
0001193125-26-073553
424B3
—
628.8 KB
424B5
Feb 26, 2026
0001193125-26-073542
424B5
—
558.4 KB
S-8
Feb 26, 2026
0001193125-26-073431
S-8
—
181.7 KB
10-K
Feb 26, 2026
0001193125-26-073395
10-K
Dec 31, 2025
18.3 MB
8-K
Feb 26, 2026
0001193125-26-073386
8-K
Feb 26, 2026
354.5 KB
4
Feb 25, 2026
0001193125-26-072155
4
Feb 25, 2026
15.6 KB
144
Feb 25, 2026
0001969223-26-000229
—
5.6 KB
4
Feb 20, 2026
0001193125-26-061686
4
Feb 20, 2026
10.3 KB
144
Feb 20, 2026
0001950047-26-001590
—
6.1 KB
SCHEDULE 13G/A
Feb 10, 2026
0000902219-26-000017
—
16.8 KB
4
Jan 20, 2026
0001193125-26-016934
4
Jan 20, 2026
15.1 KB
144
Jan 20, 2026
0001950047-26-000560
—
5.4 KB
25 filings shown